about us a message from the chairman and ceo leadership team jean jacques bienaime robert a baffi dr. henry j. fuchs dan spiegelman jeff ajer g. eric davis scott clarke joshua a. grass eduardo e. von pervieux philip lo scalzo richard ranieri board of directors history corporate and social responsibility products pipeline overview vimizim kuvan naglazyme aldurazyme firdapse pipeline pegvaliase bmn 165 for pku vosoritide bmn 111 for achondroplasia cerliponase alfa bmn 190 for cln2 disease bmn 270 for hemophilia a bmn 250 for mps iiib sanfilippo syndrome b clinical trials achondroplasia pku mps iva mps vi cln2 disease hemophilia a mps iiib sanfilippo b syndrome compassionate use policy patients physicians overview diseases lysosomal storage disorders mps i morquio a mps iva mps vi pku lems patient stories annabelle julie gina lauren liam kendra tyler semin and selim resource library patient organizations professional organizations publications glossary biomarin rareconnections global medical information medical information request form contact information investors media press releases events and presentations corporate governance management board of directors committee composition contact the board insider transactions insider ownership financial information sec filings annual reports quarterly results key ratios financial statements analyst coverage stock information historic stock lookup investment calculator dividend history ownership profile investor faq contact us email alerts funding & support guidelines for requesting grants and charitable contributions process for requesting grants applying for a grant or charitable contribution my grants faqs contact us global independent research guidelines process apply my grants faqs contact us careers innovative therapeutics rss feed my disability gives me my drive . mitch does not let living with mps vi stop him from pursuing his many passions . hear mitch s story tyler doesn t let mps vi interfere with his daily life . i try to live as normal a life i can and do the things that people my age like to do . naglazyme galsulfase helps him manage his mps vi so he can focus on achieving his dreams . read tyler s story everyone has struggles and troubles in their life she says . it s how we deal with them that matters ... read kendra s story we are literally in a race against time to get ahead of the damage caused by this disease and as parents we can not watch this happen without a fight . read annabelle s story liam used to struggle to keep his phe levels under control . but now with kuvan sapropterin dihydrochloride he is better able to manage his pku . this means he has less to worry about and can just focus on being a kid . read liam s story with five products on the market and a fully integrated multinational organization in place biomarin is providing innovative therapeutics to patients with serious unmet medical needs . view the making of naglazyme film on the treatment s journey grants learn about the grants and financial support available careers at biomarin inspired by patients powered by science latest news uk regulatory agency approves continued enrollment in biomarin phase 1 2 study of bmn 270 in hemophilia a biomarin to host third quarter 2016 financial results conference call and webcast on thursday october 27 at 4 30pm et biomarin reviews status of exon 51 composition of matter and method of use patent interference cases against sarepta therapeutics products pipeline making every day count towards a cure stock quotebmrn85 .04 1.83 2.11 % oct 16 2016 1 15 am quick links vimizim.com morquioanswers.com morquiosity.com pku.com naglazyme.com biomarin privacy statement terms of use contact us glossary 2016 biomarin . all rights reserved . top